On July 31, 2025, Mallinckrodt plc acquired Endo through a merger, where Endo became a wholly-owned subsidiary of Mallinckrodt, paying $1.31 per share in cash and issuing shares of Mallinckrodt. Additionally, the company took on $1.35 billion in senior secured credit facilities to fund this transaction and other corporate purposes.